These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 15668631)
1. Fibre diffraction of hair can provide a screening test for Alzheimer's disease: a human and animal model study. James VJ; Richardson JC; Robertson TA; Papadimitriou JM; Dutton NS; Maley MA; Berstein LM; Lantseva OE; Martins RN Med Sci Monit; 2005 Feb; 11(2):CR53-7. PubMed ID: 15668631 [TBL] [Abstract][Full Text] [Related]
2. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research. Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974 [TBL] [Abstract][Full Text] [Related]
5. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease. Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696 [TBL] [Abstract][Full Text] [Related]
6. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice. Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316 [TBL] [Abstract][Full Text] [Related]
7. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. El Tannir El Tayara N; Delatour B; Le Cudennec C; Guégan M; Volk A; Dhenain M Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798 [TBL] [Abstract][Full Text] [Related]
8. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635 [TBL] [Abstract][Full Text] [Related]
9. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. DeMattos RB; Bales KR; Cummins DJ; Paul SM; Holtzman DM Science; 2002 Mar; 295(5563):2264-7. PubMed ID: 11910111 [TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease. Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307 [TBL] [Abstract][Full Text] [Related]
11. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. Lafay-Chebassier C; Paccalin M; Page G; Barc-Pain S; Perault-Pochat MC; Gil R; Pradier L; Hugon J J Neurochem; 2005 Jul; 94(1):215-25. PubMed ID: 15953364 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice. Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020 [TBL] [Abstract][Full Text] [Related]
13. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice. Hartmann J; Erb C; Ebert U; Baumann KH; Popp A; König G; Klein J Neuroscience; 2004; 125(4):1009-17. PubMed ID: 15120860 [TBL] [Abstract][Full Text] [Related]
14. Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease. Hashimoto T; Ogino K; Shin RW; Kitamoto T; Kikuchi T; Shimizu N Neurosci Lett; 2010 Jan; 469(2):273-7. PubMed ID: 20025930 [TBL] [Abstract][Full Text] [Related]
15. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse. Lehman EJ; Kulnane LS; Gao Y; Petriello MC; Pimpis KM; Younkin L; Dolios G; Wang R; Younkin SG; Lamb BT Hum Mol Genet; 2003 Nov; 12(22):2949-56. PubMed ID: 14506131 [TBL] [Abstract][Full Text] [Related]